1.1k total citations 19 papers, 939 citations indexed
About
Brodeur Gm is a scholar working on Neurology, Molecular Biology and Cancer Research.
According to data from OpenAlex, Brodeur Gm has authored 19 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 2 papers in Molecular Biology and 2 papers in Cancer Research. Recurrent topics in Brodeur Gm's work include Neuroblastoma Research and Treatments (16 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Cholinesterase and Neurodegenerative Diseases (1 paper). Brodeur Gm is often cited by papers focused on Neuroblastoma Research and Treatments (16 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Cholinesterase and Neurodegenerative Diseases (1 paper). Brodeur Gm collaborates with scholars based in United States. Brodeur Gm's co-authors include Seeger Rc, M Favrot, Evans Ae, Frank Berthold, Victoria Castel, Jon Pritchard, Carlsen Nl, F Hedborg, J. Wasson and C. Patrick Reynolds and has published in prestigious journals such as PubMed.
In The Last Decade
Brodeur Gm
19 papers
receiving
933 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Brodeur Gm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brodeur Gm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brodeur Gm more than expected).
This network shows the impact of papers produced by Brodeur Gm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brodeur Gm. The network helps show where Brodeur Gm may publish in the future.
Co-authorship network of co-authors of Brodeur Gm
This figure shows the co-authorship network connecting the top 25 collaborators of Brodeur Gm.
A scholar is included among the top collaborators of Brodeur Gm based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Brodeur Gm. Brodeur Gm is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
19 of 19 papers shown
1.
Gm, Brodeur. (1994). Molecular pathology of human neuroblastomas.. PubMed. 11(2). 118–25.20 indexed citations
2.
Gm, Brodeur, Jon Pritchard, Frank Berthold, et al.. (1994). Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment.. PubMed. 385. 363–9.368 indexed citations
3.
Lemieux, Bernard, et al.. (1994). Screening for neuroblastoma (NB) in North America: the Quebec Project.. PubMed. 385. 377–82.7 indexed citations
4.
Fujimori, Maiko, et al.. (1994). Characterization of the region of consistent deletion within 1p36 in neuroblastomas.. PubMed. 385. 3–9.6 indexed citations
5.
Naumova, Anna K., et al.. (1994). Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.. PubMed. 385. 43–9.3 indexed citations
6.
Nakagawara, Akira, et al.. (1994). Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines.. PubMed. 385. 169–75.9 indexed citations
7.
Azar, C G, et al.. (1991). Multiple defects of the nerve growth factor receptor in human neuroblastomas.. PubMed. 366. 219–26.6 indexed citations
Gm, Brodeur. (1989). Clinical significance of genetic rearrangements in human neuroblastomas.. PubMed. 35(7 Suppl). B38–42.9 indexed citations
10.
Gm, Brodeur, Seeger Rc, A Barrett, et al.. (1988). International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma.. PubMed. 271. 509–24.73 indexed citations
11.
Rc, Seeger, et al.. (1988). Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene.. PubMed. 271. 41–9.68 indexed citations
12.
Rc, Seeger, et al.. (1988). Characterization of human neuroblastoma cell lines that lack N-myc gene amplification.. PubMed. 271. 57–69.12 indexed citations
13.
Reynolds, C. Patrick, L Donner, Lawrence Helson, et al.. (1988). Biological classification of cell lines derived from human extra-cranial neural tumors.. PubMed. 271. 291–306.79 indexed citations
14.
Tj, Moss, et al.. (1988). N-myc protein expression by neuroblastoma cells that have metastasized to bone marrow.. PubMed. 271. 91–101.6 indexed citations
15.
Gm, Brodeur, et al.. (1988). Molecular analysis and clinical significance of N-myc amplification and chromosome 1p monosomy in human neuroblastomas.. PubMed. 271. 3–15.38 indexed citations
16.
Gm, Brodeur. (1987). The involvement of oncogenes and suppressor genes in human neoplasia.. PubMed. 34. 1–44.15 indexed citations
17.
Gm, Brodeur, et al.. (1987). Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients.. PubMed. 47(16). 4248–53.155 indexed citations
18.
Gm, Brodeur. (1986). Molecular correlates of cytogenetic abnormalities in human cancer cells: implications for oncogene activation.. PubMed. 14. 229–56.10 indexed citations
19.
Gm, Brodeur, et al.. (1976). Histochemical demonstration of an increase in acetylcholinesterase in established lines of human and mouse neuroblastomas by nerve growth factor.. PubMed. 16(62). 133–8.12 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.